Comparison of the Effects of Aqueous and Gellan Ophthalmic Timolol on Peak Exercise Performance in Middle-aged Men

https://doi.org/10.1016/S0002-9394(14)70432-5Get rights and content

Purpose

To compare the effects of 0.5% aqueous timolol and 0.5% timolol gellan on exercise performance in middle-aged men.

Methods

We evaluated the effects of 0.5% aqueous timolol (timolol solution), administered twice daily, and a 0.5% timolol gellan suspension that forms a gel on application to the conjunctiva (timolol gellan), administered once daily, on exercise performance in 42 healthy men with a mean age of 58 years (range, 55 to 65 years). Serum concentrations of timolol were assayed. Subjects exercised maximally on an upright cycle ergometer four times with ten-day intervals. After baseline testing, subjects were randomly assigned and crossed over in a double-masked manner to two and a half days of treatment with placebo, 0.5% timolol solution, and 0.5% timolol gellan.

Results

The serum timolol concentrations immediately after testing were 0.91 ± 0.51 ng/ml for timolol solution compared to 0.71 ± 0.46 ng/ml for timolol gellan (P < .05). The change from baseline in resting heart rate was –1.8 ± 9.3 beats/min (P = .23) for placebo, –11.0 ± 9.6 beats/min (P < .001) for timolol solution, and –8.5 ±7.5 beats/min (P < .001) for timolol gellan. The change from baseline in peak heart rate was –0.1 ± 7.3 beats/min (P = .92) for placebo, –15.6 ± 5.6 beats/min (P < .001) for timolol solution, and –11.9 ± 8.0 beats/min (P < .001) for timolol gellan. Pair-wise comparison demonstrated significantly less reduction in both resting (P < .05) and peak heart rate (P < .01) for timolol gellan vs timolol solution.

Conclusions

Although both treatments caused reductions in resting and peak heart rate, timolol gellan was associated with significantly less reductions. The significant difference in serum concentrations of timolol between the two treatments is strong evidence that the difference in heart rate response was caused by reduced systemic absorption with timolol gellan.

References (22)

  • MB Higginbotham et al.

    Relation of stroke volume during submaximal and maximal upright exercise in normal men

    Circ Res

    (1986)
  • Cited by (47)

    • Applications of Polymers in Ocular Drug Delivery

      2020, Applications of Polymers in Drug Delivery
    • Plasma levels and systemic safety of 0.1% unpreserved Timolol maleate gel, 0.5% Timolol aqueous solution and 0.5% Timolol maleate gel

      2012, Journal Francais d'Ophtalmologie
      Citation Excerpt :

      The reduction of the dose and frequency of administration results in a reduction of the quantity of timolol absorbed into the bloodstream, thus significantly reducing the likelihood of systemic side effects compared with conventional aqueous timolol preparations. Indeed, studies using 0.5% timolol gel formulations and 0.5% timolol gel-forming solution have shown fewer systemic effects in terms of peak heart rate during exercise and pulmonary function compared to placebo or 0.5% timolol aqueous solution [21–24]. More recently, 0.1% timolol gels have proved to be clinically equi-potent to 0.5% timolol in aqueous solution [19,20] with a reduced systemic absorption and fewer side effects [20].

    • Adrenergic antagonists

      2009, Becker-Shaffer's Diagnosis and Therapy of the Glaucomas: Eighth Edition
    • Topical drug delivery in the eye

      2004, Experimental Eye Research
    View all citing articles on Scopus

    This study was supported by a grant from Merck & Co., Whitehouse Station, New Jersey.

    Reprint requests to Kenneth Dickstein, M.D., Ph.D, Cardiology Division, Central Hospital in Rogaland, Stavanger 4011, Norway; fax: 47-51519905.

    View full text